Can Observational Analyses of Routinely Collected Data Emulate Randomized Trials? Design and Feasibility of the Observational Patient Evidence for Regulatory Approval Science and Understanding Disease Project
- 12 August 2022
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 26 (2), 176-184
- https://doi.org/10.1016/j.jval.2022.07.003
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Evaluating the Impact of Database Heterogeneity on Observational Study ResultsAmerican Journal of Epidemiology, 2013
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationThe New England Journal of Medicine, 2011
- Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part IIIValue in Health, 2009
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 DiabetesDiabetes Care, 2009
- Observational Studies Analyzed Like Randomized ExperimentsEpidemiology, 2008
- For objective causal inference, design trumps analysisThe Annals of Applied Statistics, 2008
- Randomized Clinical Trials and Observational Studies: Guidelines for Assessing Respective Strengths and LimitationsJACC: Cardiovascular Interventions, 2008
- Aprotinin during Coronary-Artery Bypass Grafting and Risk of DeathThe New England Journal of Medicine, 2008
- Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research DesignsThe New England Journal of Medicine, 2000
- A Comparison of Observational Studies and Randomized, Controlled TrialsThe New England Journal of Medicine, 2000